greeksoup/ stock research
Stock research / United States / INBX / Planned sales

Inhibrx Biosciences, Inc. planned insider sales

In the last twelve months insiders at Inhibrx Biosciences, Inc. filed 5 Form 144 notices of planned sales, 2,500 shares worth $279,010 at the time of filing, from 1 seller. The latest, filed 15 September 2026: Manhard Kimberly (director), 500 shares worth $52,525, planned for around 15 September 2026 through Fidelity Brokerage Services LLC.

FiledSellerRelationshipSharesValuePlanned saleSold, per Form 4BrokerHow acquiredFiling
15 September 2026Manhard KimberlyDirector500$52,52515 September 20261,000 shares from 14 September 2026Fidelity Brokerage Services LLCOpen Market PurchaseForm 144
14 September 2026Manhard KimberlyDirector500$55,13014 September 2026None on Form 4 yetFidelity Brokerage Services LLCOpen Market PurchaseForm 144
11 September 2026Manhard KimberlyDirector500$55,88811 September 2026500 shares from 11 September 2026Fidelity Brokerage Services LLCOpen Market PurchaseForm 144
9 September 2026Manhard KimberlyDirector500$57,8989 September 20261,000 shares from 8 September 2026Fidelity Brokerage Services LLCOpen Market PurchaseForm 144
8 September 2026Manhard KimberlyDirector500$57,5708 September 2026None on Form 4 yetFidelity Brokerage Services LLCOpen Market PurchaseForm 144
A Form 144 is the notice an insider files with the SEC before selling restricted or control shares over the Rule 144 thresholds; it says what may be sold, not what was.
Read moreValue is the filer's own aggregate market value. Sold, per Form 4: the same seller's open-market sales on Form 4 from the notice's date to 90 days after, added up, as they appear on the insiders page; a holder who files no Form 4, such as some large holders, never shows one. What is a Form 144?